pillbase.ru

Briviact (in Italy: Nubriveo)

Active substance: brivaracetam

Brivaracetam

Centralised EU authorisationActive

Marketing holder: UCB Pharma SA

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 62
  • BRIVARACETAM
    TABLET, FILM COATED · BRIVARACETAM 10 mg/1
    76282-822
    Exelan Pharmaceuticals, Inc
  • BRIVARACETAM
    TABLET, FILM COATED · BRIVARACETAM 25 mg/1
    76282-823
    Exelan Pharmaceuticals, Inc
  • BRIVARACETAM
    INJECTION · BRIVARACETAM 50 mg/5mL
    42571-370
    Micro Labs Limited
  • BRIVARACETAM
    TABLET, FILM COATED · BRIVARACETAM 50 mg/1
    76282-824
    Exelan Pharmaceuticals, Inc
  • BRIVARACETAM
    TABLET, FILM COATED · BRIVARACETAM 75 mg/1
    76282-825
    Exelan Pharmaceuticals, Inc
All products in this country (62)
Import and control

Control by country

  • United StatescontrolledSchedule: CV

    Source: openFDA NDC · record 01a1208c-2eb1-75b1-9085-a551d82f2598,01a1208c-2ee1-7a65-9692-b4aba5f31021,01a1208c-30cc-7594-8d4e-0b600f8b06c5,01a1208c-30cd-73bb-93aa-17a225daa5e8,01a1208c-528c-742d-9f25-42d9223e3b06;count=62 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003898
Registration status
Active
ATC code
N03AX23
Sources
  • product · EMA · EMEA/H/C/003898 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003898 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003898 · Verified 2026-10-09